Washington Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-545
| Closed | -$37.8K | – | 558 |
|
|
2025
Q1 | $37.8K | Buy |
545
+42
| +8% | +$2.92K | ﹤0.01% | 445 |
|
|
2024
Q4 | $43.3K | Sell |
503
-402
| -44% | -$34.6K | ﹤0.01% | 462 |
|
|
2024
Q3 | $108K | Sell |
905
-250
| -22% | -$29.8K | ﹤0.01% | 343 |
|
|
2024
Q2 | $165K | Sell |
1,155
-350
| -23% | -$50K | 0.01% | 294 |
|
|
2024
Q1 | $193K | Sell |
1,505
-35
| -2% | -$4.49K | 0.01% | 283 |
|
|
2023
Q4 | $159K | Buy |
1,540
+207
| +16% | +$21.4K | 0.01% | 286 |
|
|
2023
Q3 | $121K | Buy |
1,333
+39
| +3% | +$3.55K | 0.01% | 284 |
|
|
2023
Q2 | $105K | Buy |
1,294
+494
| +62% | +$40K | ﹤0.01% | 316 |
|
|
2023
Q1 | $63.7K | Buy |
800
+200
| +33% | +$15.9K | ﹤0.01% | 380 |
|
|
2022
Q4 | $40.6K | Buy |
600
+100
| +20% | +$6.77K | ﹤0.01% | 434 |
|
|
2022
Q3 | $25K | Hold |
500
| – | – | ﹤0.01% | 514 |
|
|
2022
Q2 | $28K | Hold |
500
| – | – | ﹤0.01% | 497 |
|
|
2022
Q1 | $28K | Hold |
500
| – | – | ﹤0.01% | 521 |
|
|
2021
Q4 | $28K | Hold |
500
| – | – | ﹤0.01% | 519 |
|
|
2021
Q3 | $24K | Hold |
500
| – | – | ﹤0.01% | 652 |
|
|
2021
Q2 | $21K | Sell |
500
-8
| -2% | -$336 | ﹤0.01% | 686 |
|
|
2021
Q1 | $17K | Hold |
508
| – | – | ﹤0.01% | 696 |
|
|
2020
Q4 | $17K | Hold |
508
| – | – | ﹤0.01% | 684 |
|
|
2020
Q3 | $17K | Sell |
508
-38
| -7% | -$1.27K | ﹤0.01% | 643 |
|
|
2020
Q2 | $18K | Sell |
546
-330
| -38% | -$10.9K | ﹤0.01% | 573 |
|
|
2020
Q1 | $27K | Buy |
+876
| New | +$27K | ﹤0.01% | 492 |
|